Table 1. Comparison of the characteristics and laboratory findings between the fulminant and non-fulminant groups .
| Non-fulminant group (N = 31) | Fulminant group (N = 9) | p-value | |
| Characteristics | |||
| Male (N, %) | 25 (80.6%) | 6 (66.7%) | 0.38 |
| Age (years) | 33.32 ± 16.01 | 41.56 ± 19.96 | 0.28 |
| Hypertension | 6 (19.4%) | 2 (22.2%) | 0.85 |
| Diabetes mellitus | 1 (3.2%) | 1 (11.1%) | 0.34 |
| Hyperlipidemia | 1 (3.2%) | 0 (0%) | 0.59 |
| Uremia | 1 (3.2%) | 0 (0%) | 0.59 |
| VHD | 1 (3.2%) | 0 (0%) | 0.59 |
| Prior MI | 0 (0%) | 0 (0%) | NS |
| Prior CVA | 0 (0%) | 0 (0%) | NS |
| Manifestations | |||
| Chest pain (N, %) | 20 (64.5%) | 3 (33.3%) | 0.10 |
| Fever (N, %) | 16 (51.6%) | 4 (44.4%) | 0.73 |
| Peripheral edema (N, %) | 7 (22.6%) | 0 (0%) | 0.12 |
| Serum biochemistry data | |||
| WBC (mm3) | 10,386.13 ± 3904.52 | 14,911.11 ± 8224.18 | 0.14 |
| CRP (mg/dL) | 5.89 ± 6.73 | 4.39 ± 4.43 | 0.58 |
| CK (IU/L) | 470.03 ± 630.18 | 610.44 ± 727.60 | 0.61 |
| Troponin-I (ng/mL) | 4.12 ± 4.95 | 17.91 ± 26.04 | 0.15 |
| Na (mmol/L) | 137.06 ± 3.62 | 136.44 ± 5.39 | 0.69 |
| K (mmol/L) | 4.08 ± 0.65 | 3.99 ± 0.53 | 0.69 |
| GOT (IU/L) | 212.42 ± 861.91 | 302.22 ± 590.74 | 0.77 |
| Creatinine (IU/L) | 1.24 ± 1.77 | 1.14 ± 0.34 | 0.87 |
BUN, blood urea nitrogen; CK, creatine kinase; CRP, C-reactive protein; CVA, cardiovascular accident; GOT, glutamate oxaloacetate transaminase; K, potassium; MI, myocardial infarction; Na, sodium; NS, not statistically significant; VHD, valvular heart disease; WBC, white blood cell.